Your session is about to expire
← Back to Search
Behavioral Intervention
Digital Platform for Transgender Mental Health
N/A
Recruiting
Led By Rena Xu
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Gender diverse individuals aged 18-24 years residing in California, Oregon, Illinois, Maryland, District of Columbia, Vermont, Connecticut, Massachusetts, New Jersey, or New York
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and every 3 months through 15 months
Awards & highlights
Summary
This trial aims to test an educational app for transgender and gender-diverse young adults and their caregivers to see if it improves mental health outcomes. Participants will be split into two groups: one with immediate
Who is the study for?
This trial is for transgender and gender-diverse young adults aged 18-24, along with their caregivers. Participants must have a score of 1 or more on the PHQ-9, indicating some level of depression symptoms. Caregivers of individuals aged 15-24 are also eligible. The study aims to include a diverse group with at least half identifying as BIPOC.
What is being tested?
The trial tests an app-based educational platform designed for TGD young adults and their caregivers against usual care resources. It's randomized: one group gets immediate access to the app plus usual care; another waits six months before getting the app. Mental health outcomes will be compared over a period of up to 15 months.
What are the potential side effects?
Since this intervention is non-medical and involves using an educational digital platform, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses based on the content or support provided through the app.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a gender diverse individual, aged 18-24, living in one of the specified states.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and every 3 months through 15 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and every 3 months through 15 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Columbia Suicide Severity Rating Scale (C-SSRS)
Patient Health Questionnaire-9 (PHQ-9)
Secondary study objectives
Child-Parent Relationship Scale (CPRS)
Family Adaptability and Cohesion Scale (FACES IV), Family Communication Subscale
Family Adaptability and Cohesion Scale (FACES IV), Family Satisfaction Subscale
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Immediate AccessExperimental Treatment1 Intervention
Immediate access participants will have access to a digital app, plus usual care, after enrollment and the deployment of the app. Usual care consists of access to published resources and community support organizations, if available. The list of resources will include contact information for a suicide prevention hotline.
Group II: Deferred AccessExperimental Treatment1 Intervention
Deferred access participants will be given usual care and gain access to the digital app at 6 months. Usual care consists of access to published resources and community support organizations, if available. The list of resources will include contact information for a suicide prevention hotline.
Find a Location
Who is running the clinical trial?
Boston Children's HospitalLead Sponsor
778 Previous Clinical Trials
5,580,512 Total Patients Enrolled
Rena XuPrincipal InvestigatorBoston Children's Hospital
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger